September 21, 2017 11:15 AM ET

Pharmaceuticals

Company Overview of Nanotherapeutics, Inc.

Audit Committee of Nanotherapeutics, Inc.

Name (Connections)Board RelationshipsTitleKey Developments
James Matthew 11 RelationshipsChief Financial Officer and Director
Weaver Gaines J.D.26 RelationshipsDirector
Thomas Stagnaro 28 RelationshipsDirector

Advisory Committee*

NameBoard RelationshipsTitle Board Affiliations
Jim BlanchardMember of the Advisory Board11 Relationships
No other board affiliations
James Fitz-GeraldCo-Founder, Director and Member of the Advisory Board11 Relationships
No other board affiliations
Guy LalondeMember of the Advisory Board11 Relationships
No other board affiliations
Chad RoyMember of the Advisory Board11 Relationships
No other board affiliations
Gregory SchultzMember of the Advisory Board29 Relationships
No other board affiliations
Alistair WebbMember of the Advisory Board11 Relationships
No other board affiliations

Compensation Committee*

Name (Connections)Board RelationshipsTitle
James Butler 26 RelationshipsDirector
Robert Hennessey 11 RelationshipsChairman
Sean McConnell 11 RelationshipsDirector
Key PositionIndustry Range
No Compensation vs Industry data is available for undefined.
Nanotherapeutics, Inc.
Industry Average

Nominating Committee*

Name (Connections)Board RelationshipsTitleKey Developments
James Fitz-Gerald Ph.D.11 RelationshipsCo-Founder, Director and Member of the Advisory Board
Sean McConnell 11 RelationshipsDirectorNanotherapeutics, Inc. Appoints Robert J. Hennessey as Chairman of the Board

Corporate Governance Committee*

Name (Connections)Board RelationshipsTitle
James Fitz-Gerald Ph.D.11 RelationshipsDirector
Sean McConnell 11 RelationshipsChairman
and Competitor
Insiders vs. External
Board
Nanotherapeutics, Inc.
17%
83%
There is no Key Competitor Insiders data available

Executive Committee*

Name (Connections)Board RelationshipsTitle
James Butler 26 RelationshipsDirector
Weaver Gaines J.D.26 RelationshipsDirector
Management Effectiveness Relative to the Industry
There is no Management Effectiveness data available
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Active Committee Members by Competitor

SymbolCommittee MemberNumber of Committees
There is no Active Committee Members data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Nanotherapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.